1080
J. S. Yadav et al.
PAPER
1H NMR (300 MHz, CDCl3): d = 7.16–6.77 (m, 5 H), 5.90–5.71 (m,
2 H), 4.23 (q, J = 7.5 Hz, 2 H), 2.90–2.72 (m, 1 H), 2.61 (dd,
J = 14.3, 6.0 Hz, 1 H), 2.10 (s, 3 H), 1.31 (t, J = 7.5 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 14.1, (30.6 and 30.9), 48.6, (52.1
and 52.3), (63.1 and 63.2), (109.2 and 109.3), (124.8 and 124.9),
125.1, 126.6, 126.8, 127.7, 132.1, 143.1, 152.3, 205.8.
IR (KBr): 2923, 1716, 1621, 1524, 1466, 1397, 1374, 1343, 1266,
1233, 1113, 1034, 912, 771, 549 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.85 (d, J = 8.1 Hz, 1 H), 7.60–
7.52 (m, 1 H), 7.29–7.02 (m, 2 H), 6.64 (t, J = 7.3 Hz, 1 H), 5.89 (d,
J = 4.9 Hz, 1 H), 4.30 (q, J = 6.5 Hz, 2 H), 2.96 (dd, J = 15.5, 8.1
Hz, 1 H), 2.65 (dd, J = 15.5, 4.0 Hz, 1 H), 2.08 (s, 3 H), 1.35 (t,
J = 6.5 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 14.3, (29.5 and 30.5), (46.7 and
51.0), 49.2, (63.0 and 63.1), 102.4, (124.4 and 125.1), 126.6, 129.2,
129.4, 132.0, 133.7, 144.4, 152.0, 204.9.
ESI-MS: m/z = 282 [M + Na]+, 259.1, 246.1, 218, 202, 173.9, 153,
130.1.
HRMS: m/z calcd for C15H17NO3Na: 282.1106; found: 282.1099.
Ethyl 1-(2-Oxocyclohexyl)-1,2-dihydro-2-isoquinolinecarbox-
ESI-MS: m/z = 327 [M + Na]+, 304.1, 247, 216.9, 203, 175.
ylate (3c)
Viscous brown liquid.
HRMS: m/z calcd for C15H16N2O5Na: 327.0956; found: 327.0953.
IR (KBr): 2936, 2862, 1709, 1630, 1568, 1455, 1415, 1374, 1325,
1238, 1123, 1018, 936, 770, 539 cm–1.
Ethyl 5-Nitro-1-(2-oxocyclohexyl)-1,2-dihydro-2-isoquinoline-
carboxylate (3g)
Yellow solid, mp 125–128 °C.
1H NMR (300 MHz, CDCl3): d = 7.42–6.92 (m, 4 H), 6.80 (d,
J = 7.5 Hz, 1 H), 6.0–5.87 (m, 1 H), 5.79 (d, J = 7.5 Hz, 1 H), 4.20
(q, J = 6.7 Hz, 2 H), 2.83–2.56 (m, 2 H), 2.43–1.51 (m, 6 H), 1.41
(s, 1 H), 1.30 (t, J = 6.7 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = (14.4 and 14.5), 20.7, (26.6 and
27.4), (28.0 and 28.3), (40.3 and 41.2), (52.4 and 52.6), (53.1 and
54.5), (62.0 and 62.1), (108.3 and 108.5), (124.4 and 124.5), (125.3
and 126.3), (126.5 and 126.7), (127.3 and 127.5), (129.1 and 129.3),
(129.6 and 131.2), (130.7 and 132.6), (152.4 and 152.7), (208.5 and
209).
IR (KBr): 2925, 2855, 1713, 1615, 1522, 1458, 1403, 1373, 1338,
1264, 1178, 1119, 1022, 767, 672 cm–1.
1H NMR (300 MHz, CDCl3): d = 7.84 (dd, J = 1.5, 8.3 Hz, 1 H),
7.80–7.69 (m, 1 H), 7.20–7.01 (m, 2 H), 6.79–6.71 (m, 1 H), 5.91–
5.85 (m, 1 H), 4.26 (q, J = 6.0 Hz, 2 H), 2.78 (s, 1 H), 2.35–2.31 (m,
1 H), 2.27–2.01 (m, 3 H), 1.95 (d, J = 4.5 Hz, 2 H), 1.62 (d, J = 7.5
Hz, 2 H), 1.33 (t, J = 6.0 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 14.4, 25.1, 28.4, (31.9 and 32.5),
43.1, (52.5 and 52.6), (53.5 and 53.6), 62.9, 104.7, 124.0, 124.9,
126.5, (129.1 and 130.0), (133.4 and 133.5), 134.6, 144.5, (153.1
and 153.4), 210.2.
ESI-MS: m/z = 322.1 [M + Na]+, 202, 102, 74.2, 59.3.
Ethyl 1-(2-Oxocyclopentyl)-1,2-dihydro-2-isoquinolinecarbox-
ylate (3d)
ESI-MS: m/z = 367 [M + Na]+, 337, 301, 246.9, 160, 59.3.
Viscous brownish liquid.
Ethyl 5-Nitro-1-(2-oxocyclopentyl)-1,2-dihydro-2-isoquinoline-
IR (KBr): 2963, 2924, 1734, 1710, 1632, 1569, 1456, 1414, 1373,
1316, 1234, 1120, 1014, 926, 892, 769, 590 cm–1.
carboxylate (3h)
Yellowish liquid.
1H NMR (300 MHz, CDCl3): d = 7.19–6.92 (m, 4 H), 6.90 (d,
J = 6.7 Hz, 1 H), 5.80–5.75 (m, 1 H), 5.63 (d, J = 6.7 Hz, 1 H), 4.24
(q, J = 6.7 Hz, 2 H), 2.54–2.36 (m, 1 H), 2.21–1.91 (m, 4 H), 1.84–
1.47 (m, 2 H), 1.33 (t, J = 7.5 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 14.1, 20.0, (24.4 and 25.3), (37.0
and 37.9), 51.9, (54.2 and 54.8), 61.7, (107.4 and 107.6), 124.0,
125.2, 126.0, (126.3 and 126.4), (127.1 and 127.4), (129.3 and
129.4), (130.7 and 130.9), (152.0 and 152.1), (215.3 and 215.4).
IR (KBr): 2924, 2854, 1720, 1619, 1523, 1460, 1401, 1373, 1339,
1270, 1231, 1155, 1112, 1017, 924, 769, 590 cm–1.
1H NMR (300 MHz, CDCl3): d = 7.88 (d, J = 8.3 Hz, 1 H), 7.54 (d,
J = 7.5 Hz, 1 H), 7.29–7.06 (m, 2 H), 6.52 (d, J = 8.3 Hz, 1 H),
6.16–6.06 (m, 1 H), 4.26 (q, J = 6.7 Hz, 2 H), 2.67–2.60 (m, 2 H),
2.36–2.25 (m, 1 H), 1.93–1.48 (m, 4 H), 1.33 (t, J = 6.7 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = (14.2 and 14.4), (20.1 and 20.3),
(25.5 and 25.7), (37.9 and 38.1), 51.9, (54.2 and 54.4), 62.7, 102.0,
[124.1 and 124.4 (2 × C)], [126.2 and 126.4 (2 × C)], (130.1 and
130.5), 131.6, 144.3, (151.9 and 152.4), 215.0.
ESI-MS: m/z = 308.1 [M + Na]+, 202, 74.2, 59.3.
Ethyl 5-Nitro-1-(2-oxo-2-phenylethyl)-1,2-dihydro-2-isoquino-
linecarboxylate (3e)
Yellow solid, mp 126–128 °C.
ESI-MS: m/z = 353 [M + Na]+, 337, 319.1, 301, 284, 262, 247, 216,
59.3.
IR (KBr): 2923, 2853, 1719, 1679, 1619, 1522, 1453, 1400, 1372,
1338, 1269, 1225, 1181, 1113, 1019, 948, 883, 765, 692, 578 cm–1.
Ethyl 1-(2-Oxobutyl)-1,2-dihydro-2-isoquinolinecarboxylate
(3i)
Viscous yellow liquid.
1H NMR (300 MHz, CDCl3): d = 7.86 (m, 3 H), 7.55–7.38 (m, 4 H),
7.25–7.05 (m, 2 H), 6.76–6.66 (m, 1 H), 6.05 (s, 1 H), 4.24 (q,
J = 6.7 Hz, 2 H), 3.49 (dd, J = 8.3, 15.1 Hz, 1 H), 3.14 (dd, J = 4.5,
15.1 Hz, 1 H), 1.32 (t, J = 6.7 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 14.4, (42.7 and 42.9), (51.8 and
51.9), 62.8, 102.6, 124.4, 125.0, 126.4 (3 × C), 128.1, 128.5 (2 × C),
129.0, 132.1, 133.1, 136.6, 144.5, 152.1, 195.4.
IR (KBr): 2981, 1713, 1632, 1455, 1416, 1373, 1326, 1219, 1124,
935, 772 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.25–6.79 (m, 5 H), 5.98–5.45 (m,
2 H), 4.23 (q, J = 6.7 Hz, 2 H), 3.11–2.21 (m, 2 H), 1.90–1.70 (m,
2 H), 1.34 (t, J = 6.7 Hz, 3 H), 1.04 (t, J = 6.7 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 7.5, (14.1 and 14.4), (34.4 and
34.6), 47.1, (51.6 and 52.0), (62.3 and 62.4), (109.5 and 110.2),
(124.7 and 124.9), (125.0 and 125.3), (126.8 and 126.9), (127.8 and
127.9), 129.9, (130.1 and 131.8), 130.4, (153.3 and 15.7), (209.9
and 210.7).
ESI-MS: m/z = 389.1 [M + Na]+, 339, 319.1, 305.1, 289.1, 247,
229.1, 181, 141.1.
Ethyl 5-Nitro-1-(2-oxopropyl)-1,2-dihydro-2-isoquinolinecar-
boxylate (3f)
Viscous yellowish liquid.
ESI-MS: m/z = 296 [M + Na]+.
HRMS: m/z calcd for C16H19NO3Na: 296.1262; found: 296.1257.
Synthesis 2007, No. 7, 1077–1081 © Thieme Stuttgart · New York